Means "Flemoklav-solyutab" instruction forapplication characterizes as an antibiotic agent with a wide range of effects. The drug includes clavulanic acid and amoxicillin. The drug has a bactericidal effect. The drug is active against many microbes - gram-negative and gram-positive, aerobic and anaerobic. Admits the preparation "Flemoklav-solyutab" instruction for children and adults to take in conjunction with an antihistamine.

The maximum content of amoxicillin is noted after an hour or two after taking the medication. The component is able to penetrate into breast milk and through the placental barrier (in a small amount).

The maximum content of clavulanic acidis observed after the expiration of the order of two hours after administration. The ability of the component to penetrate breast milk has not been established. Clavulanic acid passes through the placental barrier.

The degree of absorption of the active ingredients of the preparation "Flemoclav-solutab" (the instruction for use contains such data) does not influence food intake.

The medicine is indicated for infectious diseasesand inflammatory nature, caused by pathogens that show sensitivity to it (medicine). The preparation "Flemoklav-solyutab" instruction for use recommends for lesions in soft tissues, upper and lower respiratory tract (pharyngitis, sinusitis, otitis media (middle), tonsillitis). Assign a medicine for infections of the skin, organs of the urinary tract.

During studies of teratogenic effectsdrug on the condition of a pregnant woman, fetus or newborn was not revealed. Means "Flemoklav-solyutab" instruction for use considers a safe medication and allows for appointment during the period of gestation (in the 2nd and 3rd trimester). The appointment in the first trimester of pregnancy is carried out with caution.

Despite the fact that amoxicillin is capable ofpenetrate into breast milk, a negative impact on the state of the newborn during breastfeeding on the background of taking the drug "Flemoklav-solyutab" was not noted.

The drug is contraindicated in liver dysfunction orjaundice with the use of clavulanate or amoxicillin, hypersensitivity to the components of the medication, as well as to other beta-lactam antibiotic medicines (cephalosporins, penicillins). No medication is prescribed for lymphocytic leukemia, infectious mononucleosis due to high risk of exanthema.

Assign means "Flemoklav-solutab" with caution in pathologies in the digestive tract, hepatic insufficiency (severe), renal failure (chronic).

To prevent dyspeptic manifestationsit is recommended to take the medicine before meals directly. Tablets do not soften, do not chew. It is recommended to drink with a sufficient amount of water. It is allowed to dissolve the drug in thirty milliliters of water. Before use, stir thoroughly.

The duration of the therapeutic course is determined by the doctor. As a rule, treatment does not last longer than fourteen days.

For patients whose body weight is more than forty kilograms, a dosage of 0.5 g / 125 mg is prescribed. Take should be a day three times.

The optimal therapeutic dose of the drug"Flemoclav-solute" for children from three months to two years is 125 / 32.5 mg per day twice. Children from two to 12 years increase the number of receptions up to three times a day.

When taking medication, unwantedmanifestations in the form of allergies, pseudomembranous colitis, candidamycosis, abdominal pain, etc. As practice shows, the severity of adverse reactions depends on the dosage of the drug. In many cases, undesirable phenomena are eliminated after adjusting the reception circuit.

Often appointed drug "Flemoklav-solyutab"for children. The responses of the parents are ambiguous. However, it should be noted that in general, the drug is considered highly effective and quick-acting. To the disadvantages of the drug is often attributed a high probability of side effects. But, as noted above, many unwanted reactions are eliminated after the dose adjustment.

Before taking the drug "Famoclav-solute", you should consult a doctor and study the annotation.